N

Newregen Inc
OTC:NREG

Watchlist Manager
Newregen Inc
OTC:NREG
Watchlist
Price: 0.0085 USD 7.59% Market Closed
Market Cap: $560k

Newregen Inc
Retained Earnings

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Newregen Inc
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
N
Newregen Inc
OTC:NREG
Retained Earnings
-$950.6k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Concentra Group Holdings Parent Inc
NYSE:CON
Retained Earnings
$146.4m
CAGR 3-Years
-34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Newregen Inc
Glance View

Market Cap
560k USD
Industry
N/A

Newregen, Inc. operates an anti-aging and stem cell center. The company is headquartered in Atlanta, Georgia. The company went IPO on 2013-01-09. The firm focuses on stem cell therapy, facial rejuvenation, hair rejuvenation, non-surgical hair restoration, Protein Rich Plasma (PRP) injections, and anti-aging treatments. The firm's services include orthopedic and non-surgical joint restoration, anti-aging program, and sexual wellness treatment, among others. Its specialty services include male specialty services and female specialty services. The firm operates in Atlanta, Austin, Miami, And New York. The firm's male specialty services consist of stem cell treatment for erectile dysfunction and peyronie's disease, non-surgical hair transplant, testosterone replacement therapy, and growth hormone and sermorelin. The female specialty services consist of human growth hormone (HGH) for Women and O'Shot.

NREG Intrinsic Value
Not Available
N

See Also

What is Newregen Inc's Retained Earnings?
Retained Earnings
-950.6k USD

Based on the financial report for Jan 31, 2019, Newregen Inc's Retained Earnings amounts to -950.6k USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett